Maxia Strategies-Europe

Maxia Strategies is a global regulatory affairs and clinical development consultancy that supports biotechnology and pharmaceutical companies in navigating the path to market. The firm specializes in providing strategic advice for interactions with major regulatory bodies, including the FDA and EMA, and assists with submissions such as INDs, CTAs, NDAs, and MAAs. Their expertise spans various therapeutic areas, with a particular focus on orphan drugs, oncology, and advanced therapy medicinal products (ATMPs). By bridging the gap between clinical development and regulatory requirements, Maxia Strategies enables its clients to optimize development timelines and achieve successful product approvals. The company offers specialized services in CMC strategy, pediatric development plans, and expedited program designations.